$REAL
TheRealReal, Inc. Stock $real

$real Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000157322122000066 Filed on May 10, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$154.4M	$146.7M	$145.1M
YoY Change	47.2%	48.46%	68.22%
Cost Of Revenue	$66.75M	$68.08M	$64.50M
YoY Change	60.84%	68.19%	92.82%
Gross Profit	$87.69M	$78.62M	$80.63M
YoY Change	38.28%	34.76%	52.64%
Gross Profit Margin	56.78%	53.59%	55.56%
Selling, General & Admin	$138.7M	$48.26M	$125.2M
YoY Change	213.28%	10.65%	23.08%
% of Gross Profit	158.14%	61.39%	155.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.696M	$6.364M	$5.691M
YoY Change	5.18%	17.09%	9.86%
% of Gross Profit	7.64%	8.09%	7.06%
Operating Expenses	$138.7M	$133.3M	$125.2M
YoY Change	8.16%	19.99%	23.08%
Operating Profit	-$50.98M	-$54.71M	-$44.58M
YoY Change	-21.32%	3.66%	-8.85%
Interest Expense	-$2.415M	$2.664M	-$6.041M
YoY Change	-140.21%	-19.17%	163.8%
% of Operating Profit
Other Income/Expense, Net	$266.0K	-$139.0K	$1.000K
YoY Change		-917.65%	-101.25%
Pretax Income	-$53.13M	-$57.41M	-$52.22M
YoY Change	-24.84%	2.59%	1.84%
Income Tax	$33.00K	$0.00	-$27.00K
% Of Pretax Income
Net Earnings	-$53.17M	-$57.41M	-$52.20M
YoY Change	-24.83%	2.53%	1.67%
Net Earnings / Revenue	-34.43%	-39.14%	-35.97%
Basic Earnings Per Share	-$0.56	-$0.61
Diluted Earnings Per Share	-$560.2K	-$0.61	-$563.3K
COMMON SHARES
Basic Shares Outstanding	94.37M shares	93.48M shares	92.39M shares
Diluted Shares Outstanding	94.90M shares	93.48M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$315.9M	$361.0M	$418.2M
YoY Change	-35.75%	-34.11%	17.84%
Cash & Equivalents	$69.50M	$361.0M	$418.2M
Short-Term Investments			$0.00
Other Short-Term Assets	$20.72M	$21.38M	$20.86M
YoY Change	17.47%	39.73%	21.98%
Inventory	$74.03M	$73.70M	$71.02M
Prepaid Expenses
Receivables	$6.364M	$8.176M	$7.767M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$417.0M	$464.3M	$517.8M
YoY Change	-27.37%	-24.95%	22.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$228.6M	$90.42M	$89.29M
YoY Change	192.52%	35.69%	40.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.790M	$3.266M	$2.535M
YoY Change	-0.92%	51.48%	23.66%
Total Long-Term Assets	$231.4M	$234.2M	$237.1M
YoY Change	4.08%	10.39%	29.13%
TOTAL ASSETS
Total Short-Term Assets	$417.0M	$464.3M	$517.8M
Total Long-Term Assets	$231.4M	$234.2M	$237.1M
Total Assets	$648.4M	$698.4M	$754.9M
YoY Change	-18.59%	-15.93%	24.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.052M	$6.292M	$4.503M
YoY Change	-40.5%	-32.05%	-68.61%
Accrued Expenses	$154.3M	$68.65M	$71.04M
YoY Change	180.38%	26.01%	24.52%
Deferred Revenue		$3.291M	$3.387M
YoY Change		63.89%	109.46%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$172.2M	$179.8M	$188.0M
YoY Change	7.06%	26.25%	26.79%
LONG-TERM LIABILITIES
Long-Term Debt	$448.3M	$447.7M	$348.4M
YoY Change	31.78%	33.19%	133.5%
Other Long-Term Liabilities	$135.0M	$2.099M	$2.291M
YoY Change	7563.11%	-98.52%	78.43%
Total Long-Term Liabilities	$583.3M	$2.099M	$2.291M
YoY Change	33006.07%	-99.56%	78.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$172.2M	$179.8M	$188.0M
Total Long-Term Liabilities	$583.3M	$2.099M	$2.291M
Total Liabilities	$755.5M	$767.8M	$681.8M
YoY Change	17.64%	23.67%	64.76%
SHAREHOLDERS EQUITY
Retained Earnings		-$812.1M	-$768.1M
YoY Change			44.38%
Common Stock		$1.000K	$1.000K
YoY Change		0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$107.1M	-$69.32M	$73.13M
YoY Change
Total Liabilities & Shareholders Equity	$648.4M	$698.4M	$754.9M
YoY Change	-18.59%	-15.92%	24.76%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	-$53.17M	-$57.41M	-$52.20M
YoY Change	-24.83%	2.53%	1.67%
Depreciation, Depletion And Amortization	$6.696M	$6.364M	$5.691M
YoY Change	5.18%	17.09%	9.86%
Cash From Operating Activities	-$38.55M	-$49.35M	-$18.76M
YoY Change	-4.83%	3.23%	-51.14%
INVESTING ACTIVITIES
Capital Expenditures	-$7.772M	$5.143M	-$9.679M
YoY Change	-54.64%	-13.2%	110.41%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$7.772M	-$8.447M	-$9.679M
YoY Change	-54.64%	95.08%	-122.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.205M	$637.0K	1.805M
YoY Change	-15.79%	-99.74%	-33.15%
NET CHANGE
Cash From Operating Activities	-38.55M	-$49.35M	-18.76M
Cash From Investing Activities	-7.772M	-$8.447M	-9.679M
Cash From Financing Activities	1.205M	$637.0K	1.805M
Net Change In Cash	-45.12M	-$57.16M	-26.64M
YoY Change	-19.73%	-129.02%	-443.27%
FREE CASH FLOW
Cash From Operating Activities	-$38.55M	-$49.35M	-$18.76M
Capital Expenditures	-$7.772M	$5.143M	-$9.679M
Free Cash Flow	-$30.78M	-$54.50M	-$9.085M
YoY Change	31.68%	1.42%	-73.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	TheRealReal, Inc.
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001573221
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-38953
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1234222
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Francisco Street
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94133
CY2022Q1	dei	City Area Code CityAreaCode	855
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	435-5893
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2022Q1	dei	Trading Symbol TradingSymbol	REAL
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	94373224	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361007000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	418171000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8176000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7767000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	73698000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	71015000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21379000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20859000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	464260000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	517812000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90419000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89286000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	140489000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145311000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3266000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2535000	USD
CY2022Q1	us-gaap	Assets Assets	698434000	USD
CY2021Q4	us-gaap	Assets Assets	754944000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6292000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4503000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	68653000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71042000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19518000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18253000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	85322000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	94188000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	179785000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	187986000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	138214000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	143159000	USD
CY2022Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	447653000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	348380000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2099000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2291000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	767751000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	681816000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94300104	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94300104	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92960066	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92960066	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	742802000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	841255000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-812120000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-768128000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-69317000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	698434000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	754944000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	146700000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98817000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	68083000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	40479000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	78617000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	58338000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48262000	USD
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	17961000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	15561000	USD
CY2022Q1	real	Operations And Technology Expense OperationsAndTechnologyExpense	67101000	USD
CY2021Q1	real	Operations And Technology Expense OperationsAndTechnologyExpense	51934000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43616000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	133324000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	111111000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-54707000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-52773000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	98000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	87000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	2664000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	3296000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-139000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57412000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55965000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57412000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-55993000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93476106	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93476106	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90044082	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90044082	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-57412000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-55993000	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57412000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-56004000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	637000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12964000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-57412000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-69317000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	191293000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3973000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11278000	USD
CY2021Q1	real	Purchase Of Capped Calls PurchaseOfCappedCalls	33666000	USD
CY2021Q1	real	Equity Component Of Convertible Debt Issuance Costs EquityComponentOfConvertibleDebtIssuanceCosts	3131000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	93031000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-55993000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	209905000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-57412000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-55993000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6364000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5435000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12514000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10919000	USD
CY2022Q1	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	4797000	USD
CY2021Q1	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	4755000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	193000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2022Q1	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	575000	USD
CY2021Q1	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	1469000	USD
CY2022Q1	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	641000	USD
CY2021Q1	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	1815000	USD
CY2022Q1	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	-175000	USD
CY2021Q1	real	Gain Loss On Disposition Of Property Plant Equipment And Impairment Of Software GainLossOnDispositionOfPropertyPlantEquipmentAndImpairmentOfSoftware	0	USD
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	5000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	602000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1219000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2683000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7181000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	426000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1769000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	779000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	106000	USD
CY2022Q1	real	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3655000	USD
CY2021Q1	real	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3983000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2030000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5072000	USD
CY2022Q1	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-2389000	USD
CY2021Q1	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	-2569000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-8627000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-547000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-70000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	257000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49354000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47808000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4000000	USD
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	3304000	USD
CY2021Q1	us-gaap	Payments For Software PaymentsForSoftware	2405000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5143000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5925000	USD
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	278844000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8447000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4330000	USD
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2022Q1	real	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	0	USD
CY2021Q1	real	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	33666000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	637000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3973000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	637000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	249151000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57164000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	197013000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	418171000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	350846000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361007000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	547859000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1448000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	7000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	718000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2434000	USD
CY2022Q1	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	1838000	USD
CY2021Q1	real	Capitalized Proprietary Software Development Costs Additions Not Yet Paid In Cash CapitalizedProprietarySoftwareDevelopmentCostsAdditionsNotYetPaidInCash	430000	USD
CY2022Q1	real	Issuance Costs Associated With Issuance Of Convertible Senior Notes Included In Other Accrued And Current Liabilities IssuanceCostsAssociatedWithIssuanceOfConvertibleSeniorNotesIncludedInOtherAccruedAndCurrentLiabilities	0	USD
CY2021Q1	real	Issuance Costs Associated With Issuance Of Convertible Senior Notes Included In Other Accrued And Current Liabilities IssuanceCostsAssociatedWithIssuanceOfConvertibleSeniorNotesIncludedInOtherAccruedAndCurrentLiabilities	1173000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	450000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	359000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, valuation of inventory, software development costs, stock-based compensation, incremental borrowing rates related to lease liability, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></div>
CY2022Q1	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	5100000	USD
CY2021Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	9100000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, and accounts receivable. At times, such amount may exceed federally-insured limits. The Company reduces credit risk by placing its cash and cash equivalents, and investments with major financial institutions within the United States.</span></div>As of March 31, 2022 and December 31, 2021, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the three months ended March 31, 2022 and 2021.
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361007000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	361007000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	418171000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	418171000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	141297000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	139634000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50878000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50348000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90419000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89286000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6400000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5400000	USD
CY2022Q1	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	22848000	USD
CY2021Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	23577000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	19851000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14258000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	1806000	USD
CY2021Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	14417000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	8335000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8935000	USD
CY2022Q1	real	Site Credit Liability SiteCreditLiability	9873000	USD
CY2021Q4	real	Site Credit Liability SiteCreditLiability	8738000	USD
CY2022Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8352000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	7897000	USD
CY2022Q1	real	Accrued Inventory AccruedInventory	1753000	USD
CY2021Q4	real	Accrued Inventory AccruedInventory	3513000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3291000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3387000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1741000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	USD
CY2022Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	7472000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	8300000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	85322000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	94188000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12514000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10919000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	500000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	400000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7200000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7300000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1500000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	1300000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	21314000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28261000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	27999000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	28648000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	28201000	USD
CY2022Q1	real	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	58804000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	193227000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	35495000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	157732000	USD
CY2022Q1	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	6101000	USD
CY2021Q1	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	6541000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	25000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	29950000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
	real	Number Of Lawsuits Filed NumberOfLawsuitsFiled	3	lawsuit
CY2022Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	11000000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	11000000	USD
CY2020Q4	real	Number Of Lawsuits Consolidated NumberOfLawsuitsConsolidated	2	lawsuit
CY2021Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	500000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	213400000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	213400000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-57412000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-57412000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-55993000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-55993000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93476106	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93476106	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90044082	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90044082	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31537233	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30399762	shares

Files In Submission

Name	View Source	Status
0001573221-22-000066-index-headers.html	Edgar Link	pending
0001573221-22-000066-index.html	Edgar Link	pending
0001573221-22-000066.txt	Edgar Link	pending
0001573221-22-000066-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
real-20220331.htm	Edgar Link	pending
real-20220331.xsd	Edgar Link	pending
real-20220331_cal.xml	Edgar Link	unprocessable
real-20220331_def.xml	Edgar Link	unprocessable
real-20220331_htm.xml	Edgar Link	completed
real-20220331_lab.xml	Edgar Link	unprocessable
real-20220331_pre.xml	Edgar Link	unprocessable
real-2022331xex311.htm	Edgar Link	pending
real-2022331xex312.htm	Edgar Link	pending
real-2022331xex321.htm	Edgar Link	pending
real-2022331xex322.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REAL
TheRealReal, Inc. Stock $real

2022 Q2 Form 10-Q Financial Statement

#000157322122000066 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL TheRealReal, Inc. Stock $real

2022 Q2 Form 10-Q Financial Statement

#000157322122000066 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL
TheRealReal, Inc. Stock $real